Advanced Micro Devices’ (NASDAQ:AMD) Zen CPUs Now Expected To Ship In Q1 2017- United Technologies (UTX)

Advanced Micro Devices,  (NASDAQ:AMD) [Trend Analysis] knocking active thrust in leading trading session, shares an increase of 2.96% to 10.86 with around 9.93 Million shares have changed hands in this session. Last week at the AMD Tech Summit in Sonoma, California, AMD provided an update on its upcoming Zen CPU architecture to select journalists. At the New Horizon event in Austin, Texas on Tuesday, AMD shared these details with the general public.

For starters, the Zen CPU architecture will come to market carrying the name Ryzen, with the first set of ‘Summit Ridge’ desktop CPUs now expected to ship in Q1 2017. Ryzen will be the culmination of a four-year effort by AMD to regain the market share and mindshare it has lost to Intel in the high-performance desktop market.

Jim Anderson, Senior Vice President and GM, Computing and Graphics, believes that with PC gaming hardware sales growing thanks to VR and other use cases, the “market is right for a powerful new desktop processor”. AMD, of course, believes that Ryzen is the answer. The stock is going forward its fifty-two week low with 522.00% and lagging behind from its 52-week high price with -0.41%.

Similar, the positive performance for the quarter recorded as 75.25% and for the year was 347.03%, while the YTD performance remained at 267.60%. AMD has Average True Range for 14 days of 0.52.

United Technologies Corporation (NYSE:UTX) [Trend Analysis] retains strong position in active trade, as shares scoring -0.47% to $108.76 in a active trade session, while looking at the shares volume, around 173974 shares have changed hands in this session.

<p>In a conference call with investors and analysts, United Technologies Corp. (UTX) Chairman and CEo Gregory Hayes will communicate the company’s expectation for 2017 adjusted earnings per share of $6.30 to $6.60. Sales for 2017 are expected to be $57.5 billion to $59 billion, with organic sales growth of 2 to 4 percent.

<p>UTC also reaffirms 2016 adjusted EPS expectations of $6.55 to $6.60 and sales of $57 to $58 billion, with both declared and organic year over year sales growth of 2 to 3 percent. The firm has institutional ownership of 80.30%, while insider ownership included 0.13%. UTX attains analyst recommendation of 2.40 with week’s performance of -0.37%. Investors looking further ahead will note that the Price to next year’s EPS is -0.30%.

 

About Gerard Bergeron

Gerard Bergeron covers Bio-pharmacy or healthcare sector Press Releases news updates. He has extensive three year of experience in content writing as freelance writer. He performs analysis of Healthcare Companies and provides worthy information for investor community. He is an experienced writer with a precise grasp of the English language and a clear, compelling writing style.

Leave a Reply

Your email address will not be published. Required fields are marked *